Advertisement

Loading...

Advaxis, Inc.

ADXS•PNK
Healthcare
Biotechnology
$0.60
$0.00(0.00%)
U.S. Market is Open • 12:51

Advaxis, Inc. (ADXS) Stock Overview

Explore Advaxis, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap25.7M
P/E Ratio-0.08
EPS (TTM)$-7.99
ROE121.70%
Fundamental Analysis

AI Price Forecasts

1 Month$0.62
3 Months$0.36
1 Year Target$0.00

ADXS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Advaxis, Inc. (ADXS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 70.50, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.08 and a market capitalization of 25.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
482.58%
6-Month Change
1712.46%
Year-to-Date (YTD) Change
663.02%
1-Year Change
1911.83%
3-Year Change
-66.47%
5-Year Change
-98.87%
All-Time (Max) Change
-100.00%

Contact Information

https://www.ayalapharma.com
609 452 9813
9 Deer Park Drive, Monmouth Junction, NJ, 08852

Company Facts

200 Employees
IPO DateMay 8, 2020
CountryUS

Frequently Asked Questions